SF
Publications
222
Views
89 354
Downloads
17 003
Supervised works
4
Items per page
1 - 222 of 222
Title Published in Access level OA Policy Year Views Downloads
Sclerostin blockade inhibits bone resorption through PDGF receptor signaling in osteoblast lineage cellsJCI insight
accessLevelPublic
2024 31 31
Effects of Dalcroze eurhythmics exercise versus multicomponent exercise on physical and cognitive function, and falls in older adults : the EPHYCOS randomized controlled trialAdvanced biology
accessLevelPublic
2024 10 6
Romosozumab followed by denosumab versus denosumab only : a post hoc analysis of FRAME and FRAME extensionJournal of bone and mineral research
accessLevelPublic
2024 9 9
Fracture risk based on high-resolution peripheral quantitative computed tomography measures does not vary with age in older adults-the bone microarchitecture international consortium prospective cohort studyJournal of bone and mineral research
accessLevelRestricted
2024 9 0
Maladies osseuses : ce qui a changé en 2023Revue médicale suisse
accessLevelRestricted
2024 47 2
Short-term risk of fracture is increased by deficits in cortical and trabecular bone microarchitecture independent of DXA BMD and FRAX : bone microarchitecture international consortium (BoMIC) prospective cohortsJournal of bone and mineral research
accessLevelPublic
2024 9 6
3D-modeling from hip DXA shows improved bone structure with romosozumab followed by denosumab or alendronateJournal of bone and mineral research
accessLevelPublic
2024 48 19
A meta-analysis of previous falls and subsequent fracture risk in cohort studiesOsteoporosis international
accessLevelRestricted
2024 25 0
Effect of Antidiabetic Drugs on Bone Health in Patients with Normal Renal Function and in Chronic Kidney Disease (CKD) : Insight into Clinical Challenges in the Treatment of Type 2 DiabetesJournal of clinical medicine
accessLevelPublic
2023 27 6
NADPH oxidase 4 deficiency attenuates experimental osteoarthritis in miceRMD open
accessLevelPublic
2023 145 44
Nouveaux critères de remboursement du dosage de la vitamine D : et nos patients migrants ?Revue médicale suisse
accessLevelPublic
2023 33 7
High frequency of heterozygous rare variants of the SLC34A1 and SLC9A3R1 genes in patients with atypical femur fractureEuropean journal of endocrinology
accessLevelPublic
2023 182 11
2D-3D reconstruction of the proximal femur from DXA scans: Evaluation of the 3D-Shaper softwareFrontiers in bioengineering and biotechnology
accessLevelPublic
2023 52 40
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women : systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trialsBMJ
accessLevelPublic
2023 32 7
Unusual phosphaturic mesenchymal tumor mimicking osteoid osteomaRadiology case reports
accessLevelPublic
2023 83 43
Biochemical Markers of Bone Fragility in Patients With DiabetesThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2023 50 0
A Fracture Risk Assessment Tool for High Resolution Peripheral Quantitative Computed TomographyJournal of bone and mineral research
accessLevelPublic
2023 77 59
The effects of time‐restricted eating and weight loss on bone metabolism and health: a 6‐month randomized controlled trialObesity
accessLevelPublic
2023 141 11
Mechanisms underlying the long-term and withdrawal effects of denosumab therapy on boneNature reviews. Rheumatology
accessLevelRestricted
2023 23 0
Functional brain changes in sarcopenia: evidence for differential central neural mechanisms in dynapenic older womenAging Clinical and Experimental Research
accessLevelPublic
2023 91 31
Previous fracture and subsequent fracture risk : a meta-analysis to update FRAXOsteoporosis international
accessLevelPublic
2023 31 7
Development of a personalized fall rate prediction model in community-dwelling older adults: a negative binomial regression modelling approachBMC geriatrics
accessLevelPublic
2023 39 29
Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to PragmatismNutrients
accessLevelPublic
2022 94 77
Romosozumab efficacy and safety in European patients enrolled in the FRAME trialOsteoporosis international
accessLevelPublic
2022 138 49
Associations of Calcium Intake and Calcium from Various Sources with Blood Lipids in a Population of Older Women and Men with High Calcium IntakeNutrients
accessLevelPublic
2022 110 57
Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis planOsteoporosis international
accessLevelRestricted
2022 161 0
Fracture risk following an atypical femoral fractureJournal of bone and mineral research
accessLevelPublic
2022 189 208
Regeneration of Craniofacial Bone Induced by Periosteal PumpingTissue engineering. Part C, Methods.
accessLevelRestricted
2022 158 2
Bone Microarchitecture Phenotypes Identified in Older Adults Are Associated With Different Levels of Osteoporotic Fracture RiskJournal of bone and mineral research
accessLevelPublic
2022 256 282
Prevalence of low serum alkaline phosphatase and hypophosphatasia in adult patients with atypical femur fracturesCalcified tissue international
accessLevelPublic
2022 287 222
Pathophysiology of vascular calcification and bone loss: linked disorders of ageing?Nutrients
accessLevelPublic
2021 168 99
Primary mouse osteoblast and osteoclast culturing and analysisSTAR protocols
accessLevelPublic
2021 317 153
Overweight-obesity is associated with decreased vitamin K2 levels in hemodialysis patientsClinical chemistry and laboratory medicine
accessLevelPublic
2021 234 97
A Novel HR-pQCT Image Registration Approach Reveals Sex-Specific Changes in Cortical Bone Retraction With AgingJournal of Bone and Mineral Research
accessLevelRestricted
2021 145 0
Reference microarchitectural values measured by HR-pQCT in a Franco-Swiss cohort of young adult womenOsteoporosis international
accessLevelRestricted
2021 110 0
Covid 19 - vitamine D - traitement de l'ostéoporoseRevue médicale suisse
accessLevelPublic
2021 169 153
Bone fragility in patients affected by congenital diseases non skeletal in originOrphanet Journal of Rare Diseases
accessLevelPublic
2021 162 98
Développement et évaluation des filières de l'ostéoporose en SuisseRevue médicale suisse
accessLevelPublic
2021 244 194
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5DNephrology Dialysis Transplantation
accessLevelRestricted
2021 197 4
Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative ReviewAdvances in therapy
accessLevelPublic
2021 120 141
Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison servicesOsteoporosis international
accessLevelPublic
2021 186 88
Ostéoporose - Nouvelle molécule, nouvelles directivesRevue médicale suisse
accessLevelPublic
2021 72 24
RANKL‐Induced Increase in Cathepsin K Levels Restricts Cortical Expansion in a Periostin‐Dependent Fashion: A Potential New Mechanism of Bone FragilityJournal of Bone and Mineral Research
accessLevelRestricted
2021 224 1
Lack of Adiponectin Drives Hyperosteoclastogenesis in Lipoatrophic MiceFrontiers in Cell and Developmental Biology
accessLevelPublic
2021 152 64
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment GoalsJBMR plus
accessLevelPublic
2021 131 68
Metformin: is it the well wisher of bone beyond glycemic control in diabetes mellitus?Calcified tissue international
accessLevelRestricted
2021 188 0
Oral calcitriol use, vertebral fractures, and vitamin K in hemodialysis patients: a cross‐sectional studyJournal of bone and mineral research
accessLevelRestricted
2021 127 0
The vessels-bone axis: iliac artery calcifications, vertebral fractures and vitamin K from VIKI studyNutrients
accessLevelPublic
2021 133 108
Short or long-term osteoporosis therapy with denosumab ?Journal of clinical endocrinology & metabolism
accessLevelPublic
2021 105 66
Mechanically Driven Counter‐Regulation of Cortical Bone Formation in Response to Sclerostin‐Neutralizing AntibodiesJournal of Bone and Mineral Research
accessLevelRestricted
2021 186 0
Reliability and validity of an adapted hip abductor strength measure as a potential new fall risk assessment for older persons: a study protocolBMC Geriatrics
accessLevelPublic
2021 198 64
Higher serum levels of a cathepsin K–generated periostin fragment are associated with fractures in postmenopausal women with primary hyperparathyroidism: a pilot studyOsteoporosis international
accessLevelRestricted
2021 76 0
Romosozumab : un nouveau traitement de l'ostéoporose sévèreRevue médicale suisse
accessLevelPublic
2021 998 283
Associations between age-related changes in bone microstructure and strength and dietary acid load in a cohort of community-dwelling, healthy men and postmenopausal womenThe American Journal of Clinical Nutrition
accessLevelRestricted
2020 243 5
A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvementOsteoporosis International
accessLevelPublic
2020 244 118
2020 recommendations for osteoporosis treatment according to fracture risk from the Swiss Association against Osteoporosis (SVGO)Swiss Medical Weekly
accessLevelPublic
2020 377 193
Osteoporosis in Premenopausal Women: A Clinical Narrative Review by the ECTS and the IOFThe Journal of clinical endocrinology and metabolism
accessLevelPublic
2020 103 98
Perspectives on the non-invasive evaluation of femoral strength in the assessment of hip fracture riskOsteoporosis International
accessLevelRestricted
2020 190 0
Sevelamer use, vitamin K levels, vascular calcifications and vertebral fractures in hemodialysis patients: results from the VIKI studyJournal of Bone and Mineral Research
accessLevelPublic
2020 173 336
OstéoporoseRevue médicale suisse
accessLevelPublic
2020 76 146
Hand grip strength and early mortality after hip fractureArchives of Osteoporosis
accessLevelRestricted
2020 153 0
Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extensionBone
accessLevelRestricted
2020 294 2
Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observedBone
accessLevelRestricted
2020 247 2
Zoledronate Following Denosumab Discontinuation: Partial Reassurance but No ConfidenceJournal of Bone and Mineral Research
accessLevelRestricted
2020 238 5
The role of hip abductor strength in identifying older persons at risk of falls: a diagnostic accuracy studyClinical Interventions in Aging
accessLevelPublic
2020 292 96
T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trialJournal of Bone and Mineral Research
accessLevelPublic
2020 231 62
Vitamin K and OsteoporosisNutrients
accessLevelPublic
2020 164 190
Fracture risk following intermission of osteoporosis therapyOsteoporosis International
accessLevelRestricted
2019 263 1
Further Nonvertebral Fracture Reduction Beyond 3 Years for Up to 10 Years of Denosumab TreatmentJournal of Clinical Endocrinology and Metabolism
accessLevelRestricted
2019 293 1
RANKL inhibition improves muscle strength and insulin sensitivity and restores bone massJournal of Clinical Investigation
accessLevelPublic
2019 370 323
Associations between radius low-frequency axial ultrasound velocity and bone fragility in elderly men and womenOsteoporosis International
accessLevelRestricted
2019 260 1
Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective studyThe Lancet Diabetes & Endocrinology
accessLevelRestricted
2019 318 0
Diagnosis, prevention, and treatment of bone fragility in people living with HIV: a position statement from the Swiss Association against OsteoporosisOsteoporosis International
accessLevelRestricted
2019 297 1
Algorithm for the Use of Biochemical Markers of Bone Turnover in the Diagnosis, Assessment and Follow-Up of Treatment for OsteoporosisAdvances in Therapy
accessLevelPublic
2019 246 127
Relationship Between Bone Mineral Density T‐Score and Nonvertebral Fracture Risk Over 10 Years of Denosumab TreatmentJournal of Bone and Mineral Research
accessLevelPublic
2019 278 141
Higher rates of osteoporosis treatment initiation and persistence in patients with newly diagnosed vertebral fracture when introduced in inpatients than later in outpatientsOsteoporosis International
accessLevelRestricted
2019 276 1
Consensus Statement on the Use of Bone Turnover Markers for Short-Term Monitoring of Osteoporosis Treatment in the Asia-Pacific RegionJournal of Clinical Densitometry
accessLevelPublic
2019 233 141
Diabetes and fracture riskPrimer on the metabolic bone diseases and disorders of mineral metabolism
accessLevelRestricted
2019 268 3
Hip muscle and hand-grip strength to differentiate between older fallers and non-fallers: a cross-sectional validity studyClinical Interventions in Aging
accessLevelPublic
2018 523 208
Vertebral Fractures After Discontinuation of Denosumab: A Post Hoc Analysis of the Randomized Placebo-Controlled FREEDOM Trial and Its ExtensionJournal of Bone and Mineral Research
accessLevelRestricted
2018 402 1
Romosozumab FRAME Study: A Post Hoc Analysis of the Role of Regional Background Fracture Risk on Nonvertebral Fracture OutcomeJournal of Bone and Mineral Research
accessLevelRestricted
2018 390 0
Evaluation of Radius Microstructure and Areal Bone Mineral Density Improves Fracture Prediction in Postmenopausal WomenJournal of Bone and Mineral Research
accessLevelRestricted
2018 572 0
Fermented dairy products consumption is associated with attenuated cortical bone loss independently of total calcium, protein, and energy intakes in healthy postmenopausal womenOsteoporosis International
accessLevelRestricted
2018 415 6
β-Klotho deficiency shifts the gut-liver bile acid axis and induces hepatic alterations in miceAmerican Journal of Physiology. Endocrinology and Metabolism
accessLevelRestricted
2018 360 4
Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructureOsteoporosis International
accessLevelRestricted
2018 546 1
FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to DenosumabJournal of Bone and Mineral Research
accessLevelRestricted
2018 374 0
Osteoporosis: Romosozumab to rebuild the foundations of bone strengthNature Reviews Rheumatology
accessLevelRestricted
2018 421 0
OstéoporoseRevue médicale suisse
accessLevelRestricted
2018 292 2
Phosphate wasting disorders in adultsOsteoporosis International
accessLevelRestricted
2018 378 1
Recipient rs1045642 Polymorphism Is Associated With Office Blood Pressure at 1-Year Post Kidney Transplantation: A Single Center Pharmacogenetic Cohort Pilot StudyFrontiers in Pharmacology
accessLevelPublic
2018 467 196
Selective inhibition of Src family kinases by SU6656 increases bone mass by uncoupling bone formation from resorption in miceBone
accessLevelRestricted
2018 375 2
Functional Performances on Admission Predict In-Hospital Falls, Injurious Falls, and Fractures in Older Patients: A Prospective StudyJournal of Bone and Mineral Research
accessLevelRestricted
2018 487 3
Ostéoporose chez l'insuffisant rénal: quelle évaluation et quel traitement? Place de la biopsie osseuseRevue médicale suisse
accessLevelRestricted
2018 346 1
The C-Terminal Intact Forms of Periostin (iPTN) Are Surrogate Markers for Osteolytic Lesions in Experimental Breast Cancer Bone MetastasisCalcified Tissue International
accessLevelRestricted
2018 335 0
Prevention of fractures in patients with osteoporosisThe Lancet
accessLevelRestricted
2018 429 1
Intra-rater reliability of hip abductor isometric strength testing in a standing position in older fallers and non-fallersEuropean Review of Aging and Physical Activity
accessLevelPublic
2018 415 169
OstéoporoseRevue médicale suisse
accessLevelPublic
2018 378 100
Diagnosis and management of bone fragility in diabetes: an emerging challengeOsteoporosis International
accessLevelPublic
2018 362 196
Les métamorphoses du traitement de l'ostéoporoseRevue médicale suisse
accessLevelPublic
2017 355 14
Evaluation of hip abductor and adductor strength in the elderly: a reliability studyEuropean review on aging and physical activity
accessLevelPublic
2017 454 202
Serum Levels of a Cathepsin-K Generated Periostin Fragment Predict Incident Low-Trauma Fractures in Postmenopausal Women Independently of BMD and FRAXJournal of Bone and Mineral Research
accessLevelRestricted
2017 487 0
Development of a New Immunoassay for Human Cathepsin K-Generated Periostin Fragments as a Serum Biomarker for Cortical BoneCalcified Tissue International
accessLevelRestricted
2017 483 1
Cathepsin K Controls Cortical Bone Formation by Degrading PeriostinJournal of Bone and Mineral Research
accessLevelRestricted
2017 425 1
IOF Compendium of Osteoporosis
accessLevelPublic
2017 1 018 394
Peripheral skeleton bone strength is positively correlated with total and dairy protein intakes in healthy postmenopausal womenThe American journal of clinical nutrition
accessLevelRestricted
2017 589 3
Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension studyBMC musculoskeletal disorders
accessLevelPublic
2017 450 191
Retrospective evaluation of serum CTX levels after denosumab discontinuation in patients with or without prior exposure to bisphosphonatesOsteoporosis International
accessLevelRestricted
2017 464 2
Mechanisms of diabetes mellitus-induced bone fragilityNature reviews. Endocrinology
accessLevelRestricted
2017 471 0
Osteoporosis drug treatment: duration and management after discontinuation. A position statement from the SVGO/ASCOSwiss Medical Weekly
accessLevelPublic
2017 421 202
Prepubertal Impact of Protein Intake and Physical Activity on Weight-Bearing Peak Bone Mass and Strength in MalesThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2017 492 0
Structural Basis of Bone Fragility in Young Subjects with Inflammatory Bowel Disease: A High-resolution pQCT Study of the SWISS IBD Cohort (SIBDC)Inflammatory Bowel Diseases
accessLevelRestricted
2017 523 1
Traitement médicamenteux de l'ostéoporose: durée et procédure après la fin du traitementSwiss Medical Forum
accessLevelRestricted
2017 343 1
Diabetes and BoneCalcified tissue international
accessLevelRestricted
2017 416 1
Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meetingOsteoporosis International
accessLevelRestricted
2017 422 0
hypophosphatasie de l'adulteRevue médicale suisse
accessLevelRestricted
2017 446 6
Jusqu'où et jusqu'à quand traiter l'ostéoporose?Revue médicale suisse
accessLevelPublic
2017 366 97
Fracture Prospectively Recorded From Prepuberty to Young Adulthood: Are They Markers of Peak Bone Mass and Strength in Males?Journal of Bone and Mineral Research
accessLevelRestricted
2017 467 0
Within and across-sex inheritance of bone microarchitectureThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2017 1 478 10
Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosisTherapeutic advances in musculoskeletal disease
accessLevelRestricted
2016 487 0
Le traitement séquentiel présente des avantagesLeading Opinions. Médecine Interne
accessLevelRestricted
2016 359 1
Osteoporosis drug effects on cortical and trabecular bone microstructure: a review of HR-pQCT analysesBoneKEy Reports
accessLevelPublic
2016 358 145
Traitement de l'ostéoporose : quel médicament et pour qui?La gazette médicale - info@gériatrie
accessLevelPublic
2016 472 678
Influence of Fatigue Loading and Bone Turnover on Bone Strength and Pattern of Experimental Fractures of the Tibia in MiceCalcified tissue international
accessLevelRestricted
2016 534 3
Low Lean Mass Predicts Incident Fractures Independently From FRAX: a Prospective Cohort Study of Recent RetireesJournal of bone and mineral research
accessLevelRestricted
2016 559 7
The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone ClubOsteoporosis international
accessLevelRestricted
2016 433 0
Unmet needs and current and future approaches for osteoporotic patients at high risk of hip fractureArchives of osteoporosis
accessLevelPublic
2016 461 200
Periostin action in boneMolecular and cellular endocrinology
accessLevelRestricted
2016 376 0
Mechanisms in Endrocrinology: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitusEuropean journal of endocrinology
accessLevelRestricted
2016 423 1
Occupation-dependent loading increases bone strength in menOsteoporosis international
accessLevelRestricted
2016 623 3
Romosozumab Treatment in Postmenopausal Women with OsteoporosisThe New England journal of medicine
accessLevelPublic
2016 795 1 243
Santé osseuse des retraités genevoisRevue médicale suisse
accessLevelRestricted
2015 478 2
Gene–Diet Interactions on BoneNutrition and Bone Health
accessLevelRestricted
2015 619 1
Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 yearsOsteoporosis international
accessLevelRestricted
2015 481 0
Periostin expression contributes to cortical bone loss during unloadingBone
accessLevelRestricted
2015 517 1
Calcinose cutanée associée aux connectivitesRevue médicale suisse
accessLevelRestricted
2015 999 3
Taxonomy of rare genetic metabolic bone disordersOsteoporosis international
accessLevelRestricted
2015 516 0
Additive Genetic Effects on Circulating Periostin Contribute to the Heritability of Bone MicrostructureThe Journal of clinical endocrinology and metabolism
accessLevelRestricted
2015 574 0
Sauvons l'ostéoporoseRevue médicale suisse